Form 4: uniQure N.V. Director Gut Receives Stock Options and Restricted Share Units
SEC Form 4
Director Robert Gut receives stock options and restricted share units from uniQure N.V.
Summary
- Robert Gut, a director of uniQure N.V., reported transactions involving the company's securities.
- On June 19, 2024, Gut acquired 8,080 ordinary shares and disposed of 52,245 ordinary shares.
- Gut also acquired 15,840 stock options with an exercise price of $4.57, exercisable from June 19, 2024, and expiring on June 19, 2034.
- The stock options and restricted share units vest 100% on the first anniversary of the grant date, contingent upon Gut's continued relationship with the issuer.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices. The granting of stock options and restricted share units is generally viewed favorably as it aligns management's interests with those of shareholders.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
This is a standard disclosure related to executive compensation and is common in the biotechnology industry.
Stakeholder Impact
- The granting of stock options and restricted share units can incentivize the director to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/19/2024 | Date of transaction: Acquisition of stock options and restricted share units, disposal of ordinary shares. |
| 06/19/2025 | Vesting date for stock options and restricted share units. |
| 06/19/2034 | Expiration date for stock options. |
| 06/21/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.